+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

UAE Respiratory Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028)

  • PDF Icon


  • 65 Pages
  • April 2023
  • Region: United Arab Emirates
  • Mordor Intelligence
  • ID: 5120184
The United Arab Emirates (UAE) respiratory devices market is expected to register a CAGR of 2.5% during the forecast period.

Respiratory devices, such as ventilators, nebulizers, and other respiratory devices, had an immense need to manage COVID-19 patients. COVID-19 had worse outcomes for patients with respiratory diseases. For instance, according to the study published in PLOS ONE Journal in March 2021, patients from the UAE with prior comorbidities, including asthma, COPD, and chronic renal disease, had a higher mortality rate during hospitalization. Thus, the demand for respiratory devices increased during the pandemic in the UAE. However, post-pandemic, the market is expected to gain traction over the coming years because of declining COVID-19 cases and the resumption of hospital services.

The market is driven by factors such as the increasing prevalence of respiratory disorders such as chronic obstructive pulmonary disease (COPD), tuberculosis (TB), asthma, sleep apnea, and technological advancements. For instance, according to the study published in the World Allergy Organization Journal in January 2022, the incidence of asthma in the United Arab Emirates was 13.5%. The increasing incidence of asthma in the United Arab Emirates is due to the presence of airborne pathologies due to changes in the weather conditions in the country. Hence, the demand for respiratory devices is expected to increase in the United Arab Emirates over the forecast period. Moreover, according to the study published in the World Allergy Organization Journal in October 2021, the prevalence of asthma, wheezing, and hay fever was higher in the 6- to 7-year-old group, while allergic rhinitis and atopic dermatitis were higher in the 13- to 14-year-old group in the UAE.

Furthermore, increasing R&D expenditure by innovators and generic players and technological advancements associated with respiratory devices are expected to fuel the UAE respiratory devices market. For instance, in January 2022, at Arab Health 2022, OES Medical debuted the ICU Ventilator. The Gemini-G100 is an electrically powered piston ICU ventilator with an integrated oxygen concentrator. The gadget was created for use in environments where a high-pressure oxygen supply is an issue.

Thus, all the aforementioned factors, such as the growing burden of chronic diseases and technological advancement, are expected to boost market growth over the forecast period. However, the high costs associated with the devices may hamper the market to a certain extent.

UAE Respiratory Devices Market Trends

Nebulizer by Therapeutics Devices Segment is Estimated to Witness a Healthy Growth Over the Forecast Period

A nebulizer is a drug delivery device used to provide medicines in the form of a mist that is inhaled into the lungs. Nebulizers are often used to treat asthma, cystic fibrosis, COPD, and other respiratory diseases or disorders. The fundamental advantage of nebulized medications is that they are delivered directly to the respiratory tract, allowing for larger drug concentrations in the bronchial tree and pulmonary bed with fewer side effects than the systemic approach. The segment is driven by the rising prevalence of respiratory diseases in the country.

According to the study published in Translational Medicine Communication in November 2021, autologous peripheral blood non-hematopoietic enhanced stem cell cocktail (PB-NHESC-C) was supplied as a supplement to standard care therapy through compressor (jet) nebulization. Thus, nebulization of PB-NHESC-C was found to be both safe and efficacious in the majority of these individuals. As a result, the effectiveness of nebulizers in delivering therapy, as well as the benefit of the nebulizer, are expected to drive segment growth. Thus, all the aforementioned factors are expected to boost segment growth over the forecast period.

Spirometer by Diagnostics and Monitoring Devices Segment is Expected to Hold Significant Market Share During the Forecast Period

A spirometer is an apparatus for measuring the volume of air inspired and expired by the lungs. A spirometer measures ventilation, the movement of air into and out of the lungs. The spirogram will identify two different types of abnormal ventilation patterns: obstructive and restrictive. The segment is growing due to the rising prevalence of various chronic respiratory diseases and technological advancements in the spirometer. In addition, the growing geriatric population, which is more prevalent for respiratory diseases, is expected to boost the demand for spirometer devices over the forecast period.

It aids in the maintenance of lung strength or the recovery of the lungs following an injury or disease. An incentive spirometer can help improve lung ventilation after surgery. Ventilation is the amount of air that enters the lungs when we breathe in and the amount of air that departs the lungs when we breathe out. Due to the above benefits offered by the spirometer, the demand for spirometer devices is expected to increase over the forecast period.

According to the study published in the Annals of Thoracic Surgery in May 2022, despite breakthroughs in therapy, 5-year survival rates for lung cancer, regardless of stage or type, remain low, ranging from 10% to 20%. Lung cancer was discovered to be the seventh-most frequent cancer in the UAE, with a prevalence of 2.9 per 100,000 people (UAE). Thus, with the growing burden of respiratory diseases in the country, the demand for spirometers is expected to increase over the forecast period.

UAE Respiratory Devices Market Competitor Analysis

The UAE Respiratory Devices Market is moderately competitive and consists of several major players. Some of the companies which are currently dominating the market are ResMed, Medtronic, Koninklijke Philips N.V, GE Healthcare, Fisher & Paykel Healthcare Ltd, and ICU Medical, Inc.

Additional benefits of purchasing the report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

This product will be delivered within 2 business days.

Table of Contents

1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
4.1 Market Overview
4.2 Market Drivers
4.2.1 Technological Advancements in Respiratory Devices
4.2.2 Technological Advancements
4.3 Market Restraints
4.3.1 High Cost of Devices
4.4 Porter Five Forces
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5.1 By Type
5.1.1 By Diagnostic and Monitoring Devices Spirometers Sleep Test Devices Peak Flow Meters Pulse Oximeters Others
5.1.2 By Therapeutic Devices CPAP Devices BiPAP Devices Humidifiers Nebulizers Ventilators Oxygen Concentrators Inhalers Others
5.1.3 By Disposables Masks Breathing Circuits Others
6.1 Company Profiles
6.1.1 ResMed
6.1.2 Medtronic
6.1.3 Koninklijke Philips N.V
6.1.4 GE Healthcare
6.1.5 ICU Medical (Smith Medical)
6.1.6 Fisher & Paykel Healthcare Ltd
6.1.7 Ceumed
6.1.8 Som Healthcare
6.1.9 Abu Dhabi Medical Devices Company
6.1.10 Hamilton Medical

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • ResMed
  • Medtronic
  • Koninklijke Philips N.V
  • GE Healthcare
  • ICU Medical (Smith Medical)
  • Fisher & Paykel Healthcare Ltd
  • Ceumed
  • Som Healthcare
  • Abu Dhabi Medical Devices Company
  • Hamilton Medical